Introduction Unresectable or metastatic melanoma harboring BRAF V600 (v-Raf murine sarcoma viral oncogene homolog B) mutations represent a highly aggressive disease with historically poor prognosis. Targeted therapies against BRAF have improved outcomes, but monotherapy with BRAF inhibitors is frequently associated with the development of resistanc
537 Reached
Rubella Syndrome in Neonate
1400 Reached12 Comments9 Likes
Black Lesion in Old Female
1972 Reached5 Comments11 Likes
Chronic Hyperplastic Candidiasis Of The Oral Mucosa
857 Reached9 Comments11 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes
ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes